{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:47:05Z","timestamp":1789138025361,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS116037"],"award-info":[{"award-number":["1R01NS116037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","award":["LB805"],"award-info":[{"award-number":["LB805"]}],"id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS128336"],"award-info":[{"award-number":["1R01NS128336"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010537","name":"Nebraska Department of Health and Human Services","doi-asserted-by":"publisher","award":["LB506"],"award-info":[{"award-number":["LB506"]}],"id":[{"id":"10.13039\/100010537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114266","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:51:07Z","timestamp":1758765067000},"page":"114266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lipid nanomedicine simultaneously inhibits BRD4\/PI3K and MDM2\/XIAP signaling pathways for effective treatment of Medulloblastoma"],"prefix":"10.1016","volume":"387","author":[{"given":"Bharti","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohan","family":"Mahto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaykumar","family":"Chittipolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Ronning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram I.","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114266_bb0005","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2025.114266_bb0010","series-title":"Neuroimmune Pharmacology","first-page":"959","article-title":"Pharmacogenomics of neurodegenerative diseases: roles in personalized medicines","author":"Evande","year":"2017"},{"key":"10.1016\/j.jconrel.2025.114266_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"Taylor","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2025.114266_bb0020","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1200\/JCO.2017.72.7842","article-title":"Medulloblastoma: from myth to molecular","volume":"35","author":"Ramaswamy","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114266_bb0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/neuonc\/nox155","article-title":"Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)","volume":"20","author":"Beier","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2025.114266_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-017-2627-1","article-title":"Long-term outcomes of adult medulloblastoma patients treated with radiotherapy","volume":"136","author":"De","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2025.114266_bb0035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/pbc.24496","article-title":"Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961","volume":"60","author":"Ris","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jconrel.2025.114266_bb0040","doi-asserted-by":"crossref","first-page":"11013","DOI":"10.3390\/ijms150611013","article-title":"Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells","volume":"15","author":"Yang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114266_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","article-title":"gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114266_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.2015.233","article-title":"The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours","volume":"113","author":"Thomas","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114266_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.12.055","article-title":"Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma","volume":"354","author":"Sethi","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114266_bb0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.trecan.2018.07.001","article-title":"MDM2-TP53 Crossregulation: an underestimated target to promote loss of TP53 function and cell survival","volume":"4","author":"Soussi","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2025.114266_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2013.11.002","article-title":"Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer","volume":"344","author":"Van Maerken","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114266_bb0070","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/neuonc\/nos115","article-title":"Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas","volume":"14","author":"K\u00fcnkele","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2025.114266_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1389557517666170717125821","article-title":"Nutlin-3, a p53-Mdm2 antagonist for nasopharyngeal carcinoma treatment","volume":"18","author":"Yee-Lin","year":"2018","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114266_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12943-015-0334-0","article-title":"Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival","volume":"14","author":"Liu","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114266_bb0085","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1002\/cam4.1658","article-title":"Targeting inhibitors of apoptosis proteins suppresses medulloblastoma cell proliferation via G2\/M phase arrest and attenuated neddylation of p21","volume":"7","author":"Chen","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.jconrel.2025.114266_bb0090","series-title":"Neuroimmune Pharmacology and Therapeutics","first-page":"585","article-title":"Pharmacogenomics of neurodegenerative diseases: roles in personalized medicines","author":"Gupta","year":"2024"},{"key":"10.1016\/j.jconrel.2025.114266_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122104","article-title":"Cre fused with RVG peptide mediates targeted genome editing in mouse brain cells in vivo","volume":"17","author":"Zou","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114266_bb0100","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/pbi.12719","article-title":"Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device","volume":"15","author":"Phoolcharoen","year":"2017","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.jconrel.2025.114266_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121138","article-title":"Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma","volume":"278","author":"Kumar","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114266_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122049","article-title":"Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice","volume":"295","author":"Kumar","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114266_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2020.04.053","article-title":"ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice","volume":"323","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114266_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1097-0215(20000920)89:5<395::AID-IJC1>3.0.CO;2-V","article-title":"C-MYC expression in medulloblastoma and its prognostic value","volume":"89","author":"Herms","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114266_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115423","article-title":"Synthesis and biological evaluation of dual MDM2\/XIAP inhibitors based on the tetrahydroquinoline scaffold","volume":"255","author":"Albadari","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114266_bb0130","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1021\/acs.jmedchem.0c00932","article-title":"Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a potent dual MDM2\/XIAP inhibitor","volume":"64","author":"Wu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114266_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120272","article-title":"Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures","volume":"596","author":"Gupta","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114266_bib137","doi-asserted-by":"crossref","first-page":"113902","DOI":"10.1016\/j.jconrel.2025.113902","article-title":"COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice","volume":"384","author":"Gupta","year":"2025","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:56:27Z","timestamp":1780476987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S0168365925008788"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114266","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanomedicine simultaneously inhibits BRD4\/PI3K and MDM2\/XIAP signaling pathways for effective treatment of Medulloblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114266"}}